Targeted Therapies in Cancer, Second International Congress
Author | : |
Publisher | : |
Total Pages | : 3 |
Release | : 2003 |
Genre | : |
ISBN | : |
Download Targeted Therapies in Cancer, Second International Congress Book in PDF, ePub and Kindle
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Targeted Therapies In Cancer Second International Congress PDF full book. Access full book title Targeted Therapies In Cancer Second International Congress.
Author | : |
Publisher | : |
Total Pages | : 3 |
Release | : 2003 |
Genre | : |
ISBN | : |
Author | : |
Publisher | : |
Total Pages | : 3 |
Release | : 2005 |
Genre | : |
ISBN | : |
Author | : Gw Sledge |
Publisher | : Clinical Pub |
Total Pages | : 0 |
Release | : 2012-06 |
Genre | : Breast |
ISBN | : 9781846920660 |
This new volume updates the reader on selected areas of targeted therapy in breast cancer, with special emphasis on chemoprevention strategies, drug resistance, biomarkers, combination chemotherapy, angiogenesis inhibition and pharmacogenomics in the context of clinical efficacy. This selected review of targeted therapies will guide the reader on effective treatment as part of an integrated programme of patient management.
Author | : Steven E. Schild, MD |
Publisher | : Demos Medical Publishing |
Total Pages | : 260 |
Release | : 2010-03-08 |
Genre | : Medical |
ISBN | : 1935281801 |
Thoracic Malignancies: Thoracic Malignancies is the first title in Radiation Medicine Rounds. These tumors take more lives than any others and they are among the most preventable of tumors. Thus it is crucial for the practitioner to be up-to-date on the latest insights regarding their management. Thoracic Malignancies addresses the multi-disciplinary nature of the care of these tumors. There is representation from radiation oncology, medical oncology, and surgery ensuring a well-rounded summarization of current practice. Included are chapters on lung cancer, esophageal cancer, and thymomas providing coverage of the vast majority of thoracic tumors. The multi-disciplinary nature of the articles provides readers with an up-to-date summary and a well-rounded review regarding these tumors and their care. Expert authors provide reviews and assessments of the most recent data and its implications for current clinical practice, along with insights into emerging new trends of importance for the near future. About the Series Radiation Medicine Rounds is an invited review publication providing a thorough analysis of new scientific, technologic, and clinical advances in all areas of radiation medicine. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Radiation Medicine Rounds provides authoritative, thorough assessments of a wide range of Ïhot topicsÓ and emerging new data for the entire specialty of radiation medicine. Features of Radiation Medicine Rounds include: Editorial board of nationally recognized experts across the spectrum of radiation medicine In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Radiation Medicine Issues edited by an authority in specific subject area Focuses on major topics in Radiation Medicine with in-depth articles covering advances in radiation science radiation medicine technology, radiation medicine practice, and assessment of recent quality and outcomes studies Emphasizes multidisciplinary approaches to research and practice
Author | : Marc Lacroix |
Publisher | : Nova Science Publishers |
Total Pages | : 0 |
Release | : 2016 |
Genre | : Cancer |
ISBN | : 9781634846684 |
Besides surgery, radiation therapy, endocrine therapy or chemotherapy, which were widely used in cancer patients for decades, the 21st century has seen the emergence of "targeted" therapy, resulting from the identification of molecular pathways in cells and their alterations in tumors. An increasing number of compounds targeting specific molecules or cancer cells have been developed and, for some of them, approved by the United States Food and Drug Administration (FDA) as well as other regulators in EU and Japan Additional new and more efficient types of compounds, are still in clinical trials, but are expected to gain future approval. More than eighty FDA-approved targeted therapies are described here, along with about eighty other promising compounds. These drugs are members of various therapy classes, including tyrosine kinase inhibitors; serine/threonine kinase inhibitors; dual specificity kinase inhibitors; lipid kinase inhibitors; poly ADP ribose polymerase inhibitors; monoclonal antibodies; microtubule targeting agents; histone deacetylase inhibitors; proteasome inhibitors; antimetabolites; immunomodulatory agents; DNA methyltransferase inhibitors; hedgehog pathway inhibitors; enzymes; protein translation inhibitors; vaccines, oncolytic viruses; chimeric antigen receptor T-cells (CAR-T); and so on. A series of "companion" diagnostics intended to be used as an indication for specific therapies, and approved to this aim are also mentioned. The book aims to present the broad landscape of compounds and companion diagnostics that are expected to pave the way towards a future of hope for cancer patients.
Author | : ConferenceSeries |
Publisher | : ConferenceSeries |
Total Pages | : 70 |
Release | : |
Genre | : |
ISBN | : |
Aug 29-30, 2017 London, UK Key Topics : Women Cancers, Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Vaginal Cancer/Vulvar Cancer, Breast Cancer, Gynecologic Cancers: Signs and Symptoms, Gynecologic Cancers: Treatment and Monitoring, Human papilloma Virus, HPV Vaccines, Women Health, Gynecologic Cancers: Surgical Methods, Gynecologic Cancer: Screening and Diagnosis, Gynecology Oncology, Cancer Pharmacology, Oncology Nursing and Primary care, Gynecologic Cancers: Case Report
Author | : Ahmedin Jemal |
Publisher | : |
Total Pages | : 0 |
Release | : 2015 |
Genre | : Cancer |
ISBN | : 9781604432282 |
This atlas illustrates the latest available data on the cancer epidemic, showing causes, stages of development, and prevalence rates of different types of cancers by gender, income group, and region. It also examines the cost of the disease, both in terms of health care and commercial interests, and the steps being taken to curb the epidemic, from research and screening to cancer management programs and health education.
Author | : Abbe R. Gluck |
Publisher | : PublicAffairs |
Total Pages | : 416 |
Release | : 2021-11-16 |
Genre | : Medical |
ISBN | : 1541700627 |
An unprecedented constellation of experts—leading cancer doctors, policymakers, cutting-edge researchers, national advocates, and more—explore the legacy and the shortcomings from the fifty-year war on cancer and look ahead to the future. The longest war in the modern era, longer than the Cold War, has been the war on cancer. Cancer is a complex, evasive enemy, and there was no quick victory in the fight against it. But the battle has been a monumental test of medical and scientific research and fundraising acumen, as well as a moral and ethical challenge to the entire system of medicine. In A New Deal for Cancer, some of today’s leading thinkers, activists, and medical visionaries describe the many successes in the long war and the ways in which our deeper failings as a society have held us back from a more complete success. Together they present an unrivaled and nearly complete map of the battlefield across dimensions of science, government, equity, business, the patient provider experience, and more, documenting our emerging understanding of cancer’s many unique dimensions and offering bold new plans to enable the American health care system to deliver progress and hope to all patients.
Author | : A. Brahmananda Reddy |
Publisher | : Springer Nature |
Total Pages | : 602 |
Release | : 2022-02-22 |
Genre | : Technology & Engineering |
ISBN | : 9811673896 |
This book includes original, peer-reviewed research articles from International Conference on Advances in Computer Engineering and Communication Systems (ICACECS 2021), held in VNR Vignana Jyoythi Institute of Engineering and Technology (VNR VJIET), Hyderabad, Telangana, India, during 13–14 August 2021. The book focuses on “Smart Innovations in Mezzanine Technologies, Data Analytics, Networks and Communication Systems” enlargements and reviews on the advanced topics in artificial intelligence, machine learning, data mining and big data computing, knowledge engineering, semantic Web, cloud computing, Internet on Things, cybersecurity, communication systems, and distributed computing and smart systems.
Author | : Ravi Salgia |
Publisher | : Springer |
Total Pages | : 238 |
Release | : 2019-06-26 |
Genre | : Medical |
ISBN | : 3030178323 |
This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient’s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.